Cipla, Boehringer Ingelheim to co-market 3 oral anti-diabetic drugs

Cipla, Boehringer Ingelheim to co-market 3 oral anti-diabetic drugs The three drugs are Oboravo (Empagliflozin), Oboravo Met (Empagliflozin Metformin) and Tiptengio (Empagliflozin Linagliptin).

No comments:

Post a Comment